Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Pal Rakonczai"'
Autor:
Odette S. Reifsnider, Ali Tafazzoli, Stephan Linden, Jack Ishak, Pal Rakonczai, Matthew Stargardter, Effie Kuti
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 4 (2024)
Background In the EMPEROR‐Reduced trial (Empagliflozin Outcome Trial in Patients with Chronic Heart Failure and a Reduced Ejection Fraction), empagliflozin plus standard of care reduced the composite of cardiovascular death or hospitalization for h
Externí odkaz:
https://doaj.org/article/8be347aa15bf47fe965fc52f141023d4
Autor:
Hiroyuki Tsutsui, Hiroyuki Sakamaki, Shin-ichi Momomura, Yasushi Sakata, Yutaro Kotobuki, Stephan Linden, Odette S. Reifsnider, Pal Rakonczai, Matthew Stargardter, Tatsunori Murata, Tetsuaki Hirase, Daisuke Nitta
Publikováno v:
Journal of Cardiology. 81:522-530
Autor:
Ali, Tafazzoli, Odette S, Reifsnider, Leana, Bellanca, Jack, Ishak, Marc, Carrasco, Pal, Rakonczai, Matthew, Stargardter, Stephan, Linden
Publikováno v:
The European Journal of Health Economics.
Purpose This research examined the cost-effectiveness of adding empagliflozin to standard of care (SoC) compared with SoC alone for treatment of heart failure with reduced ejection fraction (HFrEF) from the perspective of healthcare payers in the Uni